These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9853007)

  • 1. Expression and activity of urokinase and its receptor in endothelial and pulmonary epithelial cells exposed to asbestos.
    Barchowsky A; Roussel RR; Krieser RJ; Mossman BT; Treadwell MD
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):388-96. PubMed ID: 9853007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased neutrophil adherence to endothelial cells exposed to asbestos.
    Treadwell MD; Mossman BT; Barchowsky A
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):62-70. PubMed ID: 8685910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells.
    Perkins RC; Broaddus VC; Shetty S; Hamilton S; Idell S
    Am J Respir Cell Mol Biol; 1999 Nov; 21(5):637-46. PubMed ID: 10536123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors.
    Basire A; Sabatier F; Ravet S; Lamy E; Mialhe A; Zabouo G; Paul P; Gurewich V; Sampol J; Dignat-George F
    Thromb Haemost; 2006 Apr; 95(4):678-88. PubMed ID: 16601839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B
    Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen intermediate-release of fibre-exposed monocytes increases inflammatory cytokine-mRNA level, protein tyrosine kinase and NF-kappaB activity in co-cultured bronchial epithelial cells (BEAS-2B).
    Drumm K; Messner C; Kienast K
    Eur J Med Res; 1999 Jul; 4(7):257-63. PubMed ID: 10425262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nickel-induced plasminogen activator inhibitor-1 expression inhibits the fibrinolytic activity of human airway epithelial cells.
    Andrew A; Barchowsky A
    Toxicol Appl Pharmacol; 2000 Oct; 168(1):50-7. PubMed ID: 11000099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of the urokinase plasminogen activator system by oncostatin M promotes endothelial migration.
    Strand K; Murray J; Aziz S; Ishida A; Rahman S; Patel Y; Cardona C; Hammond WP; Savidge G; Wijelath ES
    J Cell Biochem; 2000 Aug; 79(2):239-48. PubMed ID: 10967551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein synthesis by chromium(VI) differentially affects expression of urokinase and its receptor in human type II pneumocytes.
    Shumilla JA; Barchowsky A
    Toxicol Appl Pharmacol; 1999 Aug; 158(3):288-95. PubMed ID: 10438662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells.
    Wickström SA; Veikkola T; Rehn M; Pihlajaniemi T; Alitalo K; Keski-Oja J
    Cancer Res; 2001 Sep; 61(17):6511-6. PubMed ID: 11522648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion.
    Mazumdar A; Adam L; Boyd D; Kumar R
    Cancer Res; 2001 Jan; 61(1):400-5. PubMed ID: 11196194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells.
    Seghezzi G; Marelli R; Mandriota SJ; Nolli ML; Mazzieri R; Mignatti P
    J Cell Physiol; 1996 Nov; 169(2):300-8. PubMed ID: 8908197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
    J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
    Foca C; Moses EK; Quinn MA; Rice GE
    Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced beta3-endonexin levels are associated with enhanced urokinase-type plasminogen activator receptor expression in ApoE-/- mice.
    Besta F; Müller I; Lorenz M; Massberg S; Bültmann A; Cabeza N; Richter T; Kremmer E; Nothdurfter C; Brand K; Gawaz M
    Thromb Res; 2004; 114(4):283-92. PubMed ID: 15381392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression.
    Serratì S; Margheri F; Fibbi G; Di Cara G; Minafra L; Pucci-Minafra I; Liotta F; Annunziato F; Pucci M; Del Rosso M
    J Pathol; 2008 Apr; 214(5):545-54. PubMed ID: 18189329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.